Effect of Hypoxia-Induced Micro-RNAs Expression on Oncogenesis.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
04 Jun 2022
Historique:
received: 13 04 2022
revised: 01 06 2022
accepted: 02 06 2022
entrez: 10 6 2022
pubmed: 11 6 2022
medline: 14 6 2022
Statut: epublish

Résumé

MicroRNAs (miRNAs) are small non-coding RNAs that negatively regulate gene expression at the post-transcriptional level. An aberrant regulation of gene expression by miRNAs is associated with numerous diseases, including cancer. MiRNAs expression can be influenced by various stimuli, among which hypoxia; however, the effects of different types of continuous hypoxia (moderate or marked) on miRNAs are still poorly studied. Lately, some hypoxia-inducible miRNAs (HRMs, hypoxia-regulated miRNAs) have been identified. These HRMs are often activated in different types of cancers, suggesting their role in tumorigenesis. The aim of this study was to evaluate changes in miRNAs expression both in moderate continuous hypoxia and marked continuous hypoxia to better understand the possible relationship between hypoxia, miRNAs, and colorectal cancer. We used RT-PCR to detect the miRNAs expression in colorectal cancer cell lines in conditions of moderate and marked continuous hypoxia. The expression of miRNAs was analyzed using a two-way ANOVA test to compare the differential expression of miRNAs among groups. The levels of almost all analyzed miRNAs (miR-21, miR-23b, miR-26a, miR-27b, and miR-145) were greater in moderate hypoxia versus marked hypoxia, except for miR-23b and miR-21. This study identified a series of miRNAs involved in the response to different types of continuous hypoxia (moderate and marked), highlighting that they play a role in the development of cancer. To date, there are no other studies that demonstrate how these two types of continuous hypoxia could be able to activate different molecular pathways that lead to a different expression of specific miRNAs involved in tumorigenesis.

Identifiants

pubmed: 35682972
pii: ijms23116294
doi: 10.3390/ijms23116294
pmc: PMC9181687
pii:
doi:

Substances chimiques

MIRN145 microRNA, human 0
MicroRNAs 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Dept. of Medical and Surgical Sciences of the University of Foggia
ID : DR n. 285-2022, Prot. N. 0014908 - III/13, 16.03.2022

Références

Ageing Res Rev. 2013 Sep;12(4):1056-68
pubmed: 23688930
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2999-3004
pubmed: 14973191
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61
pubmed: 16461460
Cancer Lett. 2015 Feb 1;357(1):384-392
pubmed: 25434799
CA Cancer J Clin. 2017 May 6;67(3):177-193
pubmed: 28248415
Cell. 2005 Jul 15;122(1):6-7
pubmed: 16009126
Mol Cell Endocrinol. 2014 Nov;397(1-2):51-8
pubmed: 25132648
Mol Cell Biochem. 2014 May;390(1-2):85-91
pubmed: 24390089
Br J Haematol. 2008 May;141(3):325-34
pubmed: 18410568
J Oncol. 2021 Apr 2;2021:5528303
pubmed: 33883997
Biochim Biophys Acta. 2013 Feb;1829(2):239-47
pubmed: 23201159
Oncotarget. 2018 Oct 12;9(80):35114-35122
pubmed: 30416683
Sci Signal. 2011 Nov 15;4(199):ra75
pubmed: 22087031
J Control Release. 2011 Feb 28;150(1):94-101
pubmed: 21146569
Cell Rep. 2016 Jul 26;16(4):967-978
pubmed: 27396342
Cell Death Dis. 2010 Oct 21;1:e85
pubmed: 21368858
J Exp Clin Cancer Res. 2016 Mar 10;35:43
pubmed: 26964533
Cancer Metastasis Rev. 2016 Jun;35(2):289-322
pubmed: 26970968
J Exp Clin Cancer Res. 2015 Aug 22;34:86
pubmed: 26297223
Nat Rev Cancer. 2002 Jan;2(1):38-47
pubmed: 11902584
Nat Commun. 2015 Jun 12;6:7318
pubmed: 26065921
J Cell Mol Med. 2014 Oct;18(10):1913-26
pubmed: 25124875
Mol Cell Biol. 2007 Mar;27(5):1859-67
pubmed: 17194750
Br J Cancer. 2015 Aug 11;113(4):634-44
pubmed: 26196183
J Biochem. 2017 May 1;161(5):417-420
pubmed: 28338957
Neuro Oncol. 2012 Aug;14(8):1026-36
pubmed: 22649212
Target Oncol. 2012 Sep;7(3):183-8
pubmed: 22890559
Clin Cardiol. 2017 Sep;40(9):704-709
pubmed: 28464406
Crit Rev Oncol Hematol. 2021 Jan;157:103124
pubmed: 33254041
RNA Biol. 2011 Sep-Oct;8(5):706-13
pubmed: 21712654
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Int J Clin Exp Pathol. 2017 Sep 01;10(9):9251-9261
pubmed: 31966797
Biomed Pharmacother. 2021 Feb;134:111099
pubmed: 33338745
Cell. 2004 Jan 23;116(2):281-97
pubmed: 14744438
Tumour Biol. 2016 Jun;37(6):7095-108
pubmed: 27039398
Nat Rev Cancer. 2008 Dec;8(12):967-75
pubmed: 18987634
Crit Rev Oncol Hematol. 2017 May;113:22-27
pubmed: 28427511

Auteurs

Giorgia Moriondo (G)

Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.

Giulia Scioscia (G)

Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.
Institute of Respiratory Diseases, "Policlinico Riuniti" University Hospital of Foggia, 71122 Foggia, Italy.

Piera Soccio (P)

Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.

Pasquale Tondo (P)

Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.

Cosimo Carlo De Pace (CC)

Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.

Roberto Sabato (R)

Institute of Respiratory Diseases, "Policlinico Riuniti" University Hospital of Foggia, 71122 Foggia, Italy.

Maria Pia Foschino Barbaro (MP)

Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.
Institute of Respiratory Diseases, "Policlinico Riuniti" University Hospital of Foggia, 71122 Foggia, Italy.

Donato Lacedonia (D)

Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.
Institute of Respiratory Diseases, "Policlinico Riuniti" University Hospital of Foggia, 71122 Foggia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH